◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CELU

Celularity Inc. (CELU) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-16

Celularity Inc. (CELU) operates in the Biotechnology industry and is headquartered in Florham Park, United States with about 115 employees. Its market capitalization is roughly $23 million. In the fiscal year ended 2025-12-31, CELU reported $27M in revenue and ($92M) in net income.

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking.

Interactive charts & full statements → Open the CELU valuation workbench →

CELU Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$27M$54M$23M$18M
Gross Profit$6M$39M$7M($2M)
Operating Income (EBIT)($61M)($39M)($76M)($148M)
Net Income($92M)($58M)($196M)$14M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CELU Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$4M$5M$6M$11M$18M
Gross Profit($3M)$1M$0M$8M$11M
Operating Income (EBIT)($22M)($13M)($16M)($10M)($10M)
Net Income($24M)($23M)($24M)($20M)($13M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CELU Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid($6M)$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CELU Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CELU Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$107M$133M$144M$401M
Total Liabilities$145M$124M$103M$202M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CELU viewer.

Other Companies in Biotechnology

← CELHAll stocksCELZ →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.